Literature DB >> 9298675

The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage.

X M Yuan1, W Li, A G Olsson, U T Brunk.   

Abstract

Oxidized low-density lipoprotein (ox-LDL) has been shown to degrade poorly within the secondary lysosomes of macrophages but its possible effect on lysosomal integrity has received less attention. The effect of ultraviolet-C oxidized LDL (UVox-LDL) on cellular viability, and lysosomal membrane stability, was examined on cultured murine J-774 cells and human monocyte-derived macrophages (HMDMs). The acridine orange (AO) relocalization test was applied to study the lysosomal integrity of living cells. UVox-LDL dramatically reduced J-774 cell proliferation at a concentration of 25 microg/ml. Incubation with 5 microM copper alone, normally used to induce LDL oxidation, was also toxic. In contrast to the effects of ox-LDL, in concentrations up to 75 microg/ml, native LDL (nLDL) rather stimulated J-774 cell replication. Incubation with UVox-LDL (25-75 microg/ml) also altered cellular AO uptake, depending on time and dose: its lysosomal accumulation decreased and its cytosolic accumulation increased. This shift indicates damaged lysosomal membranes with decreased intralysosomal, and increased cytosolic, H+ concentration. Many J-774 cells exposed to UVox-LDL initially transformed into foam cells and then assumed an apoptotic-type morphology with TUNEL-positive nuclei. We conclude that ox-LDL is cytotoxic to macrophages due to oxidative damage of lysosomal membranes, with ensuing destabilization and leakage to the cytosol of lysosomal contents, such as hydrolytic enzymes, causing degeneration of apoptotic type.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298675     DOI: 10.1016/s0021-9150(97)00094-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Lysosome-targeted stress reveals increased stability of lipofuscin-containing lysosomes.

Authors:  Yuri Stroikin; Hanna Mild; Uno Johansson; Karin Roberg; Karin Ollinger
Journal:  Age (Dordr)       Date:  2008-01-11

Review 2.  NLRP3 inflammasomes link inflammation and metabolic disease.

Authors:  Dominic De Nardo; Eicke Latz
Journal:  Trends Immunol       Date:  2011-07-04       Impact factor: 16.687

3.  Lysosomes, cholesterol and atherosclerosis.

Authors:  W Gray Jerome
Journal:  Clin Lipidol       Date:  2010-12-01

4.  Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation.

Authors:  Veerle Bieghs; Sofie M A Walenbergh; Tim Hendrikx; Patrick J van Gorp; Fons Verheyen; Steven W Olde Damink; Ad A Masclee; Ger H Koek; Marten H Hofker; Christoph J Binder; Ronit Shiri-Sverdlov
Journal:  Liver Int       Date:  2013-04-25       Impact factor: 5.828

5.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.

Authors:  Peter Duewell; Hajime Kono; Katey J Rayner; Cherilyn M Sirois; Gregory Vladimer; Franz G Bauernfeind; George S Abela; Luigi Franchi; Gabriel Nuñez; Max Schnurr; Terje Espevik; Egil Lien; Katherine A Fitzgerald; Kenneth L Rock; Kathryn J Moore; Samuel D Wright; Veit Hornung; Eicke Latz
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

Review 6.  Cathepsin D--many functions of one aspartic protease.

Authors:  Petr Benes; Vaclav Vetvicka; Martin Fusek
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-08       Impact factor: 6.312

7.  Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention.

Authors:  Sofie M A Walenbergh; Tom Houben; Sander S Rensen; Veerle Bieghs; Tim Hendrikx; Patrick J van Gorp; Yvonne Oligschlaeger; Mike L J Jeurissen; Marion J J Gijbels; Wim A Buurman; Anita C E Vreugdenhil; Jan Willem M Greve; Jogchum Plat; Marten H Hofker; Satish Kalhan; Jussi Pihlajamäki; Patrick Lindsey; Ger H Koek; Ronit Shiri-Sverdlov
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

Review 8.  The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management.

Authors:  Tulasi Yadati; Tom Houben; Albert Bitorina; Ronit Shiri-Sverdlov
Journal:  Cells       Date:  2020-07-13       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.